Cargando…

Evaluating 2-[(18)F]FDG-PET in differential diagnosis of dementia using a data-driven decision model

2-[(18)F]fluoro-2-deoxy-d-glucose positron emission tomography (2-[(18)F]FDG-PET) has an emerging supportive role in dementia diagnostic as distinctive metabolic patterns are specific for Alzheimer's disease (AD), dementia with Lewy bodies (DLB) and frontotemporal dementia (FTD). Previous studi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gjerum, Le, Frederiksen, Kristian Steen, Henriksen, Otto Mølby, Law, Ian, Bruun, Marie, Simonsen, Anja Hviid, Mecocci, Patrizia, Baroni, Marta, Dottorini, Massimo Eugenio, Koikkalainen, Juha, Lötjönen, Jyrki, Hasselbalch, Steen Gregers
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229490/ https://www.ncbi.nlm.nih.gov/pubmed/32417727 http://dx.doi.org/10.1016/j.nicl.2020.102267

Ejemplares similares

Comparison of the clinical impact of 2-[(18)F]FDG-PET and cerebrospinal fluid biomarkers in patients suspected of Alzheimer’s disease
por: Gjerum, Le, et al.
Publicado: (2021)

Prognostic value of complementary biomarkers of neurodegeneration in a mixed memory clinic cohort
por: Gramkow, Mathias Holsey, et al.
Publicado: (2020)

Hybrid FDG PET/MRI vs. FDG PET and CT in patients with suspected dementia – A comparison of diagnostic yield and propagated influence on clinical diagnosis and patient management
por: Kaltoft, Nicolai Stefan, et al.
Publicado: (2019)

Detecting frontotemporal dementia syndromes using MRI biomarkers
por: Bruun, Marie, et al.
Publicado: (2019)

A zero-dose synthetic baseline for the personalized analysis of [(18)F]FDG-PET: Application in Alzheimer’s disease
por: Hinge, Christian, et al.
Publicado: (2022)

Evaluating combinations of diagnostic tests to discriminate different dementia types
por: Bruun, Marie, et al.
Publicado: (2018)

Biochemical Markers of Physical Exercise on Mild Cognitive Impairment and Dementia: Systematic Review and Perspectives
por: Jensen, Camilla Steen, et al.
Publicado: (2015)

Biomarkers for Alzheimer's Disease in Saliva: A Systematic Review
por: Gleerup, Helena Sophia, et al.
Publicado: (2019)

Impact of a clinical decision support tool on prediction of progression in early-stage dementia: a prospective validation study
por: Bruun, Marie, et al.
Publicado: (2019)

Lactoferrin in cerebrospinal fluid and saliva is not a diagnostic biomarker for Alzheimer's disease in a mixed memory clinic population
por: Gleerup, Helena Sophia, et al.
Publicado: (2021)

Estimation of brain amyloid accumulation using deep learning in clinical [(11)C]PiB PET imaging
por: Ladefoged, Claes Nøhr, et al.
Publicado: (2023)

Are CSF Biomarkers Useful as Prognostic Indicators in Diagnostically Unresolved Cognitively Impaired Patients in a Normal Clinical Setting
por: Schjønning Nielsen, Malene, et al.
Publicado: (2016)

Progression of Blood-Brain Barrier Leakage in Patients with Alzheimer’s Disease as Measured with the Cerebrospinal Fluid/Plasma Albumin Ratio Over Time
por: Musaeus, Christian Sandøe, et al.
Publicado: (2023)

cCOG: A web‐based cognitive test tool for detecting neurodegenerative disorders
por: Rhodius‐Meester, Hanneke F.M., et al.
Publicado: (2020)

Resting State EEG in Exercise Intervention Studies: A Systematic Review of Effects and Methods
por: Gramkow, Mathias Holsey, et al.
Publicado: (2020)

Effects of aerobic exercise on event-related potentials related to cognitive performance: a systematic review
por: Gusatovic, Julia, et al.
Publicado: (2022)

Patients with Alzheimer's disease who carry the APOE ε4 allele benefit more from physical exercise
por: Jensen, Camilla Steen, et al.
Publicado: (2019)

Aerobic exercise does not affect serum neurofilament light in patients with mild Alzheimer’s disease
por: Frederiksen, Kristian Steen, et al.
Publicado: (2023)

Effect of physical exercise on markers of neuronal dysfunction in cerebrospinal fluid in patients with Alzheimer's disease
por: Jensen, Camilla Steen, et al.
Publicado: (2017)

Five-class differential diagnostics of neurodegenerative diseases using random undersampling boosting
por: Tong, Tong, et al.
Publicado: (2017)

Elevated CSF inflammatory markers in patients with idiopathic normal pressure hydrocephalus do not promote NKCC1 hyperactivity in rat choroid plexus
por: Lolansen, Sara Diana, et al.
Publicado: (2021)

Differential diagnosis of neurodegenerative diseases using structural MRI data
por: Koikkalainen, Juha, et al.
Publicado: (2016)

Data-Driven Differential Diagnosis of Dementia Using Multiclass Disease State Index Classifier
por: Tolonen, Antti, et al.
Publicado: (2018)

Comparing a Single Clinician Versus a Multidisciplinary Consensus Conference Approach for Dementia Diagnostics
por: Thorlacius-Ussing, Gorm, et al.
Publicado: (2021)

Automatic MRI Quantifying Methods in Behavioral-Variant Frontotemporal Dementia Diagnosis
por: Cajanus, Antti, et al.
Publicado: (2018)

Physical Exercise May Increase Plasma Concentration of High-Density Lipoprotein-Cholesterol in Patients With Alzheimer’s Disease
por: Jensen, Camilla Steen, et al.
Publicado: (2020)

Quantitative Electroencephalography Analyzed by Statistical Pattern Recognition as a Diagnostic and Prognostic Tool in Mild Cognitive Impairment: Results from a Nordic Multicenter Cohort Study
por: Schjønning Nielsen, Malene, et al.
Publicado: (2018)

Saliva Neurofilament Light Chain Is Not a Diagnostic Biomarker for Neurodegeneration in a Mixed Memory Clinic Population
por: Gleerup, Helena Sophia, et al.
Publicado: (2021)

Selection of memory clinic patients for CSF biomarker assessment can be restricted to a quarter of cases by using computerized decision support, without compromising diagnostic accuracy
por: Rhodius-Meester, Hanneke F. M., et al.
Publicado: (2020)

Improved Classification of Alzheimer's Disease Data via Removal of Nuisance Variability
por: Koikkalainen, Juha, et al.
Publicado: (2012)

Hashimoto's encephalopathy: Follow‐up data from neuropsychology, lumbar puncture, and FDG‐PET
por: Lagström, Ronja Maria Birgitta, et al.
Publicado: (2019)

A 16-Week Aerobic Exercise Intervention Does Not Affect Hippocampal Volume and Cortical Thickness in Mild to Moderate Alzheimer’s Disease
por: Frederiksen, Kristian Steen, et al.
Publicado: (2018)

Neuron-derived extracellular vesicles in blood reveal effects of exercise in Alzheimer’s disease
por: Delgado-Peraza, Francheska, et al.
Publicado: (2023)

Thalamic Atrophy Without Whole Brain Atrophy Is Associated With Absence of 2-Year NEDA in Multiple Sclerosis
por: Hänninen, Katariina, et al.
Publicado: (2019)

Thalamic Atrophy Predicts 5-Year Disability Progression in Multiple Sclerosis
por: Hänninen, Katariina, et al.
Publicado: (2020)

Effects of White Matter Hyperintensities on Verbal Fluency in Healthy Older Adults and MCI/AD
por: Kaskikallio, Alar, et al.
Publicado: (2021)

Gait Disturbances are Associated with Increased Cognitive Impairment and Cerebrospinal Fluid Tau Levels in a Memory Clinic Cohort
por: Muurling, Marijn, et al.
Publicado: (2020)

Cerebrospinal fluid oxidative stress metabolites in patients with bipolar disorder and healthy controls: a longitudinal case-control study
por: Knorr, Ulla, et al.
Publicado: (2019)

Multi-Method Analysis of MRI Images in Early Diagnostics of Alzheimer's Disease
por: Wolz, Robin, et al.
Publicado: (2011)

Cerebrospinal fluid osmolality cannot predict development or surgical outcome of idiopathic normal pressure hydrocephalus
por: Oernbo, Eva Kjer, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7cgj7jtgsamakgkne51u2idg35